IVERIC bio, Inc. Common Stock
ISEE
ISEE was delisted on the 10th of July, 2023.
137 hedge funds and large institutions have $113M invested in IVERIC bio, Inc. Common Stock in 2016 Q4 according to their latest regulatory filings, with 40 funds opening new positions, 49 increasing their positions, 32 reducing their positions, and 91 closing their positions.
53% more repeat investments, than reductions
Existing positions increased: 49 | Existing positions reduced: 32
2% more call options, than puts
Call options by funds: $9.71M | Put options by funds: $9.55M
28% less funds holding
Funds holding: 191 → 137 (-54)
56% less first-time investments, than exits
New positions opened: 40 | Existing positions closed: 91
75% less funds holding in top 10
Funds holding in top 10: 4 → 1 (-3)
93% less capital invested
Capital invested by funds: $1.58B → $113M (-$1.46B)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
+$68.1M |
| 2 |
TCP
Tourbillon Capital Partners
New York
|
+$40.4M |
| 3 |
BIM
Bogle Investment Management
Newton Lower Falls,
Massachusetts
|
+$38M |
| 4 |
Millennium Management
New York
|
+$26.1M |
| 5 |
Two Sigma Advisers
New York
|
+$15.2M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$176M |
| 2 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$167M |
| 3 |
JCG
JHL Capital Group
Chicago,
Illinois
|
-$138M |
| 4 |
O
OrbiMed
New York
|
-$53.8M |
| 5 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$43.8M |
ISEE Hedge Fund Activity: Q4 2016 in Review
137 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in IVERIC bio, Inc. Common Stock (ISEE) for Q4 2016, worth a combined $113M — down 93% from $1.58B a quarter earlier.
Sellers outnumbered buyers: 91 funds closed out of ISEE and 40 opened new positions — a net loss of 51 holders — while 32 trimmed existing stakes and 49 added.
The largest buyer was Stonepine Capital Management, opening a new position worth an estimated $68.1M. The largest seller was Fidelity Investments, exiting entirely with an estimated $176M sold.
- 137 institutional investors held IVERIC bio, Inc. Common Stock (ISEE) as of Q4 2016, down from 191 in Q3 2016.
- Funds reported $113M of IVERIC bio, Inc. Common Stock stock for Q4 2016, down 93% quarter-over-quarter.
- 40 funds opened new IVERIC bio, Inc. Common Stock positions in Q4 2016 and 91 closed out, a net change of -51 holders.
- The largest IVERIC bio, Inc. Common Stock buyer in Q4 2016 was Stonepine Capital Management, an estimated $68.1M added.
- The largest IVERIC bio, Inc. Common Stock seller in Q4 2016 was Fidelity Investments, an estimated $176M sold.
Based on aggregated 13F filings for Q4 2016.